probenecid has been researched along with Leishmaniasis, Visceral in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mandal, G | 1 |
| Sarkar, A | 1 |
| Saha, P | 1 |
| Singh, N | 1 |
| Sundar, S | 1 |
| Chatterjee, M | 1 |
1 other study available for probenecid and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates.
Topics: Adenosine Triphosphate; Animals; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; | 2009 |